Updated Jul 16, 2026
MOORE ALISON is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $21K.
Alison Moore is a corporate executive known for her roles as Chief Technical Officer and President and CEO at Codexis, Inc. and Artiva Biotherapeutics, Inc. She has been involved in the development of enzymatic solutions for pharmaceutical manufacturing.
| Role | Insider |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-09 | CDXS | CODEXIS, INC. | S — Open-market sale | 3.8K | $1.31 | $5K |
| 2025-10-13 | CDXS | CODEXIS, INC. | S — Open-market sale | 6.2K | $2.51 | $16K |
| 2024-10-10 | CDXS | CODEXIS, INC. | A — Grant or award | 50.0K | $0.00 |
Alison Moore is a corporate executive known for her roles as Chief Technical Officer and President and CEO at Codexis, Inc. and Artiva Biotherapeutics, Inc. She has been involved in the development of enzymatic solutions for pharmaceutical manufacturing.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($21K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MOORE ALISON profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.